Titre : Cônes de croissance

Cônes de croissance : Questions médicales fréquentes

Termes MeSH sélectionnés :

Attention Deficit and Disruptive Behavior Disorders
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cônes de croissance : Questions médicales les plus fréquentes", "headline": "Cônes de croissance : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cônes de croissance : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-08", "dateModified": "2025-04-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cônes de croissance" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Axones", "url": "https://questionsmedicales.fr/mesh/D001369", "about": { "@type": "MedicalCondition", "name": "Axones", "code": { "@type": "MedicalCode", "code": "D001369", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.145" } } }, "about": { "@type": "MedicalCondition", "name": "Cônes de croissance", "alternateName": "Growth Cones", "code": { "@type": "MedicalCode", "code": "D020439", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Michihiro Igarashi", "url": "https://questionsmedicales.fr/author/Michihiro%20Igarashi", "affiliation": { "@type": "Organization", "name": "Department of Neurochemistry and Molecular Cell Biology, School of Medicine and Graduate School of Medical/Dental Sciences, Niigata University, Niigata, 951-8510, Japan." } }, { "@type": "Person", "name": "Daniel M Suter", "url": "https://questionsmedicales.fr/author/Daniel%20M%20Suter", "affiliation": { "@type": "Organization", "name": "Department of Biological Sciences, Purdue University, West Lafayette, IN, USA. dsuter@purdue.edu." } }, { "@type": "Person", "name": "Yimin Zou", "url": "https://questionsmedicales.fr/author/Yimin%20Zou", "affiliation": { "@type": "Organization", "name": "Neurobiology Section, Biological Sciences Division, University of California San Diego, La Jolla, CA 92093 yzou@ucsd.edu." } }, { "@type": "Person", "name": "Jeffrey van Haren", "url": "https://questionsmedicales.fr/author/Jeffrey%20van%20Haren", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Snehal S Mahadik", "url": "https://questionsmedicales.fr/author/Snehal%20S%20Mahadik", "affiliation": { "@type": "Organization", "name": "Program in Molecular, Cellular, and Developmental Biology, Department of Molecular Biosciences, The University of Kansas, 1200 Sunnyside Avenue, 5049 Haworth Hall, Lawrence, KS 66045." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Treatment of childhood disruptive behavior disorders and callous-unemotional traits: a systematic review and two multilevel meta-analyses.", "datePublished": "2023-03-01", "url": "https://questionsmedicales.fr/article/36859562", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jcpp.13774" } }, { "@type": "ScholarlyArticle", "name": "Pharmacotherapy of Disruptive Behaviors in Children with Intellectual Disabilities.", "datePublished": "2022-07-04", "url": "https://questionsmedicales.fr/article/35781194", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s40272-022-00517-y" } }, { "@type": "ScholarlyArticle", "name": "Exploring real-time functional magnetic resonance imaging neurofeedback in adolescents with disruptive behavior disorder and callous unemotional traits.", "datePublished": "2023-10-16", "url": "https://questionsmedicales.fr/article/37852585", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jad.2023.10.036" } }, { "@type": "ScholarlyArticle", "name": "The conduct and oppositional defiant disorder scales (CODDS) for disruptive behaviour disorders.", "datePublished": "2022-07-23", "url": "https://questionsmedicales.fr/article/35961152", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.psychres.2022.114744" } }, { "@type": "ScholarlyArticle", "name": "Short-Term Impact of \"Amaka Amasanyufu\" Multiple Family Group Intervention on Mental Health Functioning of Children With Disruptive Behavior Disorders in Uganda.", "datePublished": "2023-03-08", "url": "https://questionsmedicales.fr/article/36898607", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jaac.2022.12.028" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Cellules", "item": "https://questionsmedicales.fr/mesh/D002477" }, { "@type": "ListItem", "position": 3, "name": "Neurones", "item": "https://questionsmedicales.fr/mesh/D009474" }, { "@type": "ListItem", "position": 4, "name": "Neurofibres", "item": "https://questionsmedicales.fr/mesh/D009412" }, { "@type": "ListItem", "position": 5, "name": "Axones", "item": "https://questionsmedicales.fr/mesh/D001369" }, { "@type": "ListItem", "position": 6, "name": "Cônes de croissance", "item": "https://questionsmedicales.fr/mesh/D020439" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cônes de croissance - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cônes de croissance", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cônes de croissance", "description": "Comment identifier un cône de croissance ?\nQuels tests sont utilisés pour étudier les cônes de croissance ?\nLes cônes de croissance peuvent-ils être visualisés in vivo ?\nQuels marqueurs sont utilisés pour les cônes de croissance ?\nPeut-on évaluer la fonction des cônes de croissance ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cônes de croissance", "description": "Quels symptômes indiquent un dysfonctionnement des cônes de croissance ?\nLes cônes de croissance affectent-ils le comportement ?\nComment les cônes de croissance sont-ils liés à la douleur ?\nLes troubles de la croissance neuronale causent-ils des symptômes physiques ?\nLes symptômes neurologiques sont-ils toujours présents avec des cônes de croissance anormaux ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cônes de croissance", "description": "Peut-on prévenir les anomalies des cônes de croissance ?\nQuel rôle joue l'environnement dans le développement des cônes de croissance ?\nLes facteurs génétiques influencent-ils les cônes de croissance ?\nComment le stress maternel impacte-t-il le développement neuronal ?\nLes vaccinations influencent-elles le développement neuronal ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cônes de croissance", "description": "Quels traitements existent pour les troubles liés aux cônes de croissance ?\nLa chirurgie peut-elle corriger des anomalies des cônes de croissance ?\nLes médicaments peuvent-ils aider à la régénération des cônes de croissance ?\nY a-t-il des thérapies innovantes pour les cônes de croissance ?\nComment la réhabilitation aide-t-elle les patients ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cônes de croissance", "description": "Quelles complications peuvent survenir avec des cônes de croissance anormaux ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications neurologiques sont-elles fréquentes ?\nLes complications peuvent-elles être prévenues ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cônes de croissance", "description": "Quels sont les facteurs de risque pour les anomalies des cônes de croissance ?\nLe tabagisme maternel est-il un facteur de risque ?\nL'exposition à des toxines affecte-t-elle les cônes de croissance ?\nLes troubles génétiques augmentent-ils le risque ?\nLe manque de soins prénatals est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier un cône de croissance ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'observation microscopique des neurones en culture permet d'identifier les cônes de croissance." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour étudier les cônes de croissance ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques comme la microscopie à fluorescence et l'immunohistochimie sont couramment utilisées." } }, { "@type": "Question", "name": "Les cônes de croissance peuvent-ils être visualisés in vivo ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des techniques d'imagerie avancées permettent de visualiser les cônes de croissance in vivo." } }, { "@type": "Question", "name": "Quels marqueurs sont utilisés pour les cônes de croissance ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs comme la tubuline et la protéine GAP-43 sont souvent utilisés pour les identifier." } }, { "@type": "Question", "name": "Peut-on évaluer la fonction des cônes de croissance ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests fonctionnels mesurent la capacité des cônes à diriger la croissance axonale." } }, { "@type": "Question", "name": "Quels symptômes indiquent un dysfonctionnement des cônes de croissance ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies dans la croissance neuronale peuvent entraîner des troubles neurologiques." } }, { "@type": "Question", "name": "Les cônes de croissance affectent-ils le comportement ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans leur développement peuvent influencer le comportement et les fonctions cognitives." } }, { "@type": "Question", "name": "Comment les cônes de croissance sont-ils liés à la douleur ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des cônes de croissance mal orientés peuvent contribuer à des douleurs neuropathiques." } }, { "@type": "Question", "name": "Les troubles de la croissance neuronale causent-ils des symptômes physiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles peuvent entraîner des déficits moteurs ou sensoriels selon la région affectée." } }, { "@type": "Question", "name": "Les symptômes neurologiques sont-ils toujours présents avec des cônes de croissance anormaux ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, mais des anomalies peuvent augmenter le risque de troubles neurologiques." } }, { "@type": "Question", "name": "Peut-on prévenir les anomalies des cônes de croissance ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines anomalies peuvent être évitées par une bonne nutrition et des soins prénatals." } }, { "@type": "Question", "name": "Quel rôle joue l'environnement dans le développement des cônes de croissance ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Un environnement enrichi peut favoriser un développement neuronal sain et fonctionnel." } }, { "@type": "Question", "name": "Les facteurs génétiques influencent-ils les cônes de croissance ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des mutations génétiques peuvent affecter le développement et la fonction des cônes." } }, { "@type": "Question", "name": "Comment le stress maternel impacte-t-il le développement neuronal ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Le stress maternel peut nuire au développement des cônes de croissance et à la santé neuronale." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles le développement neuronal ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations ne nuisent pas au développement neuronal et sont essentielles pour la santé." } }, { "@type": "Question", "name": "Quels traitements existent pour les troubles liés aux cônes de croissance ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie physique, la médication et la rééducation neurologique." } }, { "@type": "Question", "name": "La chirurgie peut-elle corriger des anomalies des cônes de croissance ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, la chirurgie peut être envisagée pour corriger des malformations structurelles." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à la régénération des cônes de croissance ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments favorisent la régénération axonale et la plasticité neuronale." } }, { "@type": "Question", "name": "Y a-t-il des thérapies innovantes pour les cônes de croissance ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et cellulaires sont en cours d'étude pour améliorer la régénération neuronale." } }, { "@type": "Question", "name": "Comment la réhabilitation aide-t-elle les patients ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La réhabilitation aide à restaurer les fonctions perdues et à améliorer la qualité de vie." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des cônes de croissance anormaux ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles neurologiques, des déficits moteurs et des douleurs chroniques." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être atténuées par des traitements précoces et appropriés." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent réduire la qualité de vie en limitant les activités quotidiennes." } }, { "@type": "Question", "name": "Les complications neurologiques sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications neurologiques sont courantes chez les patients avec des anomalies des cônes." } }, { "@type": "Question", "name": "Les complications peuvent-elles être prévenues ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être prévenues par un suivi médical régulier et des interventions précoces." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les anomalies des cônes de croissance ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des infections prénatales et des toxines environnementales." } }, { "@type": "Question", "name": "Le tabagisme maternel est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme pendant la grossesse augmente le risque d'anomalies du développement neuronal." } }, { "@type": "Question", "name": "L'exposition à des toxines affecte-t-elle les cônes de croissance ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines environnementales peut nuire au développement neuronal." } }, { "@type": "Question", "name": "Les troubles génétiques augmentent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles génétiques sont associés à des anomalies dans le développement des cônes." } }, { "@type": "Question", "name": "Le manque de soins prénatals est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un manque de soins prénatals peut augmenter le risque de complications neurologiques." } } ] } ] }

Sources (10000 au total)

Treatment of childhood disruptive behavior disorders and callous-unemotional traits: a systematic review and two multilevel meta-analyses.

Children with callous-unemotional (CU) traits are at high lifetime risk of antisocial behavior. It is unknown if treatments for disruptive behavior disorders are as effective for children with CU trai... We systematically searched PsycINFO, PubMed, Cochran Library (Trials), EMBASE, MEDLINE, APA PsycNet, Scopus, and Web of Science. Eligible studies were randomized controlled trials, controlled trials, ... Sixty studies with 9,405 participants were included (M... DBD+CU children improve with treatment, but their greater DBD symptom severity requires specialized treatment modules that could be implemented alongside parenting programs. Conclusions are tempered b...

Exploring real-time functional magnetic resonance imaging neurofeedback in adolescents with disruptive behavior disorder and callous unemotional traits.

Adolescents with increased callous unemotional traits (CU traits) in the context of disruptive behavior disorder (DBD) show a persistent pattern of antisocial behavior with shallow affect and a lack o... In this explorative randomized controlled trial we randomly assigned twenty-seven adolescents with DBD to individualized real-time functional magnetic resonance neurofeedback (rtfMRI-NF) or behavioral... The rtfMRI-NF (n = 11) and TAU (n = 10) completers showed comparable and significant clinical improvement indicating neither superiority nor inferiority of rtfMRI-NF. The exploratory LMM revealed succ... This exploratory study demonstrated feasibility and suggests clinical efficacy of individualized rtfMRI-NF comparable to active TAU for adolescents with DBD and increased CU traits. Further studies ar...

The conduct and oppositional defiant disorder scales (CODDS) for disruptive behaviour disorders.

This study evaluates the clinical validity of a five-minute instrument, the Conduct and Oppositional Defiant Disorder Scales (CODDS), for assessing oppositional defiant disorder (ODD) and conduct diso...

Short-Term Impact of "Amaka Amasanyufu" Multiple Family Group Intervention on Mental Health Functioning of Children With Disruptive Behavior Disorders in Uganda.

We evaluate the mid-intervention (8 weeks) and short-term (16 weeks) impact of a culturally adapted multiple family group (MFG) intervention, "Amaka Amasanyufu," on the mental health of children with ... We analyzed data from the Strengthening mental health and research training in Sub-Saharan Africa (SMART) Africa-Uganda study. Schools were randomized to the following: a control group; an MFG facilit... There were significant group-by-time interactions for all outcomes, and differences were observed mid-intervention, with short-term effects at 16 weeks (end-intervention). MFG-PP and MFG-CHW children ... Amaka Amasanyufu MFG intervention is effective for reducing depressive symptoms and improving self-concept among children with DBDs while reducing parental stress and mental health problems among care... SMART Africa (Strengthening Mental Health Research and Training); https://clinicaltrials.gov/: NCT03081195....

Some critical comments on the paper titled "Some critical considerations in applying the construct of psychopathy to research and classification of childhood disruptive behavior disorders".

Frick (2022) presented a narrative review of some literature and made several critical comments regarding the extension of the full psychopathy construct to research and classification of childhood di...

Polygenic risk scores for antisocial behavior in relation to amygdala morphology across an attention deficit hyperactivity disorder case-control sample with and without disruptive behavior.

Antisocial and aggressive behaviors show considerable heritability and are central to disruptive behavior disorders (DBDs), but are also frequently observed in attention deficit hyperactivity disorder...

Differential Effects of Disruptive Mood Dysregulation Disorder Comorbidity in Attention Deficit Hyperactivity Disorder on Social Cognition and Empathy.

This study aimed to investigate social cognition and empathy properties in children among Disruptive Mood Dysregulation Disorder (DMDD) + Attention and Hyperactivity Disorder(ADHD); ADHD and healthy c... Twenty-two children with DMDD were compared to matched 30 children with ADHD and 60 healthy controls. We administered Affective Reactivity Index (ARI), KaSi Empathy Scale, Kiddie-SADS, and Reading Min... DMDD + ADHD group had lower performance in ToM skills and empathy than in two groups. The ARI scores were found to be statistically significantly higher in the DMDD group than in two groups. It was al... These results might be important to understand the difficulties in social functioning and interpersonal relationship in children with DMDD and ADHD. Children with DMDD may attend specific therapeutic ...